We are live on
!
Find out more
Calamos Advisors Portfolio holdings
AUM
$28.2B
1-Year Est. Return
21.78%
This Fund
S&P 500
This Quarter
Est. Return
+3.98%
1 Year Est. Return
+21.78%
3 Year Est. Return
+69.57%
5 Year Est. Return
+92%
10 Year Est. Return
+282.63%
AUM
$15.1B
AUM Growth
+$134M
(+0.89%)
Cap. Flow
-$3.91B
Cap. Flow
% of AUM
-25.89%
Top 10 Holdings %
Top 10 Hldgs %
18.53%
Holding
722
New
62
Increased
243
Reduced
170
Closed
71
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
MetLife
MET
|
+$92.3M |
| 2 |
Microsoft
MSFT
|
+$73.7M |
| 3 |
ExxonMobil
XOM
|
+$73.7M |
| 4 |
Starbucks
SBUX
|
+$72.3M |
| 5 |
Procter & Gamble
PG
|
+$54M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
MLU
METLIFE, INC. COM EQUITY UNIT
MLU
|
+$130M |
| 2 |
SLB Ltd
SLB
|
+$108M |
| 3 |
UTX.PRA
UNITED TECHNOLOGIES CORP CORP UNIT (DE)
UTX.PRA
|
+$82M |
| 4 |
Eaton
ETN
|
+$72.7M |
| 5 |
CELG
Celgene Corp
CELG
|
+$57M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 12.08% |
| 2 | Technology | 11.12% |
| 3 | Healthcare | 9.42% |
| 4 | Consumer Discretionary | 8.48% |
| 5 | Industrials | 7.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
451
Nice
NICE
$5.29B
| $544K | ﹤0.01% |
+10,740
| New | +$484K |
|
|
SNI
452
DELISTED
Scripps Networks Interactive, Inc Common Class A
SNI
| $538K | ﹤0.01% |
7,145
-320
| -4% | -$24.4K |
|
453
Armstrong World Industries
AWI
$6.86B
| $537K | ﹤0.01% |
10,500
| – | – |
|
454
ON Semiconductor
ON
$33.8B
| $527K | ﹤0.01% |
52,025
-2,580
| -5% | -$22.7K |
|
455
Synaptics
SYNA
$4.41B
| $515K | ﹤0.01% |
7,475
-365
| -5% | -$24.4K |
|
|
PSIX
456
Power Solutions International
PSIX
$691M
| $508K | ﹤0.01% |
+9,850
| New | +$584K |
|
457
Affiliated Managers Group
AMG
$9.46B
| $507K | ﹤0.01% |
2,387
-1,635
| -41% | -$325K |
|
|
NVRO
458
DELISTED
NEVRO CORP.
NVRO
| $504K | ﹤0.01% |
+13,026
| New | +$410K |
|
459
Calix
CALX
$2.27B
| $501K | ﹤0.01% |
+50,010
| New | +$498K |
|
460
Teradyne
TER
$54.8B
| $499K | ﹤0.01% |
25,205
-1,235
| -5% | -$23.3K |
|
461
Dave & Buster's
PLAY
$343M
| $483K | ﹤0.01% |
+17,710
| New | +$386K |
|
462
Jazz Pharmaceuticals
JAZZ
$15.9B
| $475K | ﹤0.01% |
2,900
-190,531
| -99% | -$31.6M |
|
|
PAY
463
DELISTED
Verifone Systems Inc
PAY
| $474K | ﹤0.01% |
12,730
-11,515
| -47% | -$405K |
|
|
PVTB
464
DELISTED
PrivateBancorp Inc
PVTB
| $473K | ﹤0.01% |
14,150
-12,000
| -46% | -$375K |
|
|
IMPV
465
DELISTED
Imperva, Inc.
IMPV
| $468K | ﹤0.01% |
+9,470
| New | +$379K |
|
466
Gentherm
THRM
$1.31B
| $454K | ﹤0.01% |
+12,400
| New | +$485K |
|
|
TBHC
467
DELISTED
The Brand House Collective
TBHC
| $444K | ﹤0.01% |
18,800
+840
| +5% | +$16.4K |
|
468
Ionis Pharmaceuticals
IONS
$9.35B
| $441K | ﹤0.01% |
7,140
-7,710
| -52% | -$380K |
|
|
WBC
469
DELISTED
WABCO HOLDINGS INC.
WBC
| $440K | ﹤0.01% |
4,200
| – | – |
|
470
PRA Group
PRAA
$648M
| $436K | ﹤0.01% |
7,525
-6,000
| -44% | -$354K |
|
471
Motorola Solutions
MSI
$69.4B
| $431K | ﹤0.01% |
6,428
| – | – |
|
472
Infosys
INFY
$45B
| $429K | ﹤0.01% |
+54,520
| New | +$441K |
|
|
IIP
473
DELISTED
INTERNAP NETWORK SERVICES CORPORATION
IIP
| $425K | ﹤0.01% |
+53,400
| New | +$425K |
|
474
MaxLinear
MXL
$6.49B
| $419K | ﹤0.01% |
56,600
| – | – |
|
|
FMI
475
DELISTED
Foundation Medicine, Inc.
FMI
| $407K | ﹤0.01% |
18,310
-4,235
| -19% | -$97.7K |
|
Similar funds
PCH
N
TWC
FDCDDQ
NA
Calamos Advisors's Q4 2014 Portfolio in Review
As of Q4 2014, Calamos Advisors held 722 positions worth $15.1B, up 0.89% from $15B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Calamos Advisors withdrew a net $3.91B in Q4 2014, closing 71 positions and reducing 170 holdings. Its most notable exit was METLIFE, INC. COM EQUITY UNIT, an estimated $130M position sold in full.
By sector, the portfolio is most concentrated in Financials at 12% of assets, up from 12% a quarter earlier, followed by Technology and Healthcare.
Against the trend, Calamos Advisors opened a new position in Northrop Grumman worth $29.4M.
- Calamos Advisors's largest Q4 2014 buy was Northrop Grumman: 199,438 shares worth $29.4M.
- Calamos Advisors added most to MetLife in Q4 2014, an estimated $92.3M increase.
- Calamos Advisors's biggest Q4 2014 reduction was SLB Ltd, cutting an estimated $108M.
- Calamos Advisors fully exited METLIFE, INC. COM EQUITY UNIT in Q4 2014, selling an estimated $130M.
- Calamos Advisors's ten largest holdings make up 19% of its $15.1B portfolio in Q4 2014.
- Calamos Advisors opened 62 new positions and closed 71 in Q4 2014.
- Calamos Advisors's portfolio value rose 0.89% quarter-over-quarter to $15.1B.
Based on Calamos Advisors's 13F filing for Q4 2014, filed 13 Feb 2015.